International Implications of 35 U.S.C. Sec. 271(e)(1), the “Safe Harbor” Provision of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch/Waxman Act), American Chemical Society Annual Meeting
This event has already occurred.
Did the Supreme Court Get It Right?: A Discussion of the Implications of Helsinn v. Teva on the Biotech/Pharma Industry